Elderly woman recovering from hip fracture applies testosterone gel and exercises with therapist in bright rehab setting.
Elderly woman recovering from hip fracture applies testosterone gel and exercises with therapist in bright rehab setting.
Àwòrán tí AI ṣe

Testosterone gel plus exercise may limit visceral fat gain in older women recovering from hip fractures

Àwòrán tí AI ṣe
Ti ṣayẹwo fun ododo

A University of Connecticut-led clinical trial found that older women recovering from a recent hip fracture who used a topical testosterone gel alongside a structured exercise program did not experience the typical rise in visceral abdominal fat seen during recovery. Researchers followed participants for six months and assessed body composition with imaging scans.

As people age, body fat can shift from just under the skin to deeper deposits in the abdomen known as visceral fat, which has been linked to higher risks of conditions including diabetes and heart disease.

Jacob Earp, an assistant professor of kinesiology at the University of Connecticut, said sex hormones appear to play a role in this redistribution.

"As men and women age, there's an unhealthy redistribution of fat from the more innocuous regions into the visceral compartment," Earp said, adding, "There is a direct link between sex hormones and fat distribution throughout the body."

Earp and colleagues tested whether adding topical testosterone therapy to rehabilitation could influence fat distribution after hip fracture. The study tracked 66 women aged 65 and older who were recovering from a recent hip fracture. All participants completed a structured exercise program, and one group also received a testosterone gel.

After six months, follow-up body-composition scans found overall body fat levels were similar between groups, but fat distribution differed: women who used the testosterone gel had lower visceral fat levels, while the group that did not receive the hormone showed an increase in visceral fat.

The findings were published in the journal Obesity Pillars. Researchers said the results suggest hormone treatment combined with exercise could be a potential strategy to improve metabolic health during recovery, though broader studies would be needed to confirm benefits and assess risks.

Ohun tí àwọn ènìyàn ń sọ

Initial reactions on X are limited and mostly neutral, consisting of summaries highlighting the study's finding that testosterone gel combined with exercise may prevent visceral fat gain in older women recovering from hip fractures, with some noting potential recovery benefits.

Awọn iroyin ti o ni ibatan

Realistic illustration contrasting social stigma: neutral for overweight, positive for exercise weight loss, negative for Ozempic users.
Àwòrán tí AI ṣe

Study finds people who use Ozempic-like drugs for weight loss face added stigma

Ti AI ṣe iroyin Àwòrán tí AI ṣe Ti ṣayẹwo fun ododo

People who lose weight using GLP-1 medications such as Ozempic and Wegovy may be judged more negatively than those who lose weight through diet and exercise — and even more negatively than people who do not lose weight at all — according to a new study led by Rice University psychologist Erin Standen.

Researchers at Vanderbilt Health discovered that both popular weight loss drugs and bariatric surgery significantly reduce fat mass while causing modest losses in fat-free mass, including muscle, in patients with obesity. The findings, based on over 3,000 patients, show improvements in overall body composition over 24 months. Maintaining this balance is crucial for long-term health, the study emphasizes.

Ti AI ṣe iroyin

New research from Turkey shows that men with obesity tend to develop more abdominal fat and liver stress, while women exhibit higher inflammation and cholesterol levels. These findings, presented at the European Congress on Obesity in Istanbul, highlight sex-based differences that could inform personalized treatments. The study analyzed patients treated between 2024 and 2025.

Researchers at the University of California, San Francisco, have discovered a mechanism by which exercise helps protect the brain from age-related damage associated with Alzheimer's disease. Physical activity prompts the liver to release an enzyme that repairs the blood-brain barrier, reducing inflammation and improving memory in older mice. The findings, published in the journal Cell, highlight a body-to-brain pathway that could lead to new therapies.

Ti AI ṣe iroyin Ti ṣayẹwo fun ododo

A year-long observational study in Japan suggests that people with type 2 diabetes who tend to overeat in response to tempting food cues such as sight and smell may see greater weight loss—and possibly better blood-sugar improvement—after starting GLP-1 receptor agonists, while those with primarily emotional eating patterns show less consistent links to long-term outcomes.

Promising animal studies from University of Colorado Boulder offer hope for osteoarthritis patients through a single injection that repairs damaged joints in weeks. Affecting one in six people over 30—with no cure—the disease limits daily activities, but this therapy targets root causes beyond pain management or surgery.

Ti AI ṣe iroyin Ti ṣayẹwo fun ododo

University of Oklahoma scientists report that the hormone FGF21 reduces body weight in obese mice by acting on a hindbrain pathway—centered on the nucleus of the solitary tract and area postrema—that relays signals to the parabrachial nucleus. The team says the mechanism overlaps anatomically with brain regions implicated in GLP-1 drugs, but appears to promote weight loss mainly by increasing metabolic rate rather than primarily suppressing food intake.

Ojú-ìwé yìí nlo kuki

A nlo kuki fun itupalẹ lati mu ilọsiwaju wa. Ka ìlànà àṣírí wa fun alaye siwaju sii.
Kọ